Evidence of a connection to another thyroid cancer-related syndrome (MEN1) was recently demonstrated in breast cancer [31], but a possible link to MEN2A is novel and, if confirmed, would represent an unusual case of a gain-of-function mutation linked to breast cancer risk. Here, RET is linked to breast cancer.